A Special Type of Government Scrutiny: Pharmaceutical Manufacturer Relationships with Specialty Pharmacies: Part I

An area that has garnered considerable government scrutiny of late is the relationships between pharmaceutical manufacturers and specialty pharmacies. In this two-part series, we explore the development of the specialty pharmacy market and the risks associated with these relationships and outline reasonable controls to mitigate the risks based upon recent enforcement actions.

Click here to view part II of this article.

This article was originally published in Bloomberg Law

Click here for a PDF of the full text